A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Study to Evaluate the Safety and Efficacy of Benrali21Jmab 30 mg sc in Patients with Sewre Asthma Uncontrolled on Standard of care Treatment

Project: Other project

StatusFinished
Effective start/end date10/12/1710/11/19

Funding

  • AstraZeneca LP: $19,320.38